In August 2025, the FDA approved an ANDA for Fosfomycin Tromethamine Granules for Oral Solution, 3 grams (Single-Dose Sachet), submitted by Aurobindo Pharma USA, Inc. This approval underscores the FDA's ongoing efforts to facilitate the availability of generic medications in the U.S. market.
In November 2025, the UK's Food Standards Agency (FSA) implemented the Genetic Technology (Precision Breeding) Regulations 2025, allowing businesses to apply for marketing authorizations for Precision Bred Organisms (PBOs) in food and feed. This regulatory development reflects the UK's commitment to advancing genetic technologies in the food sector. (food.gov.uk)
In December 2025, the FSA updated its guidance on the application process for PBOs, emphasizing the importance of conducting a Tier 1 safety assessment and obtaining a marketing notice from the Department for Environment, Food & Rural Affairs (Defra) before applying for authorization. This update aims to streamline the application process and ensure the safety of PBOs in the market. (food.gov.uk)
In January 2026, the FSA provided guidance on the transportation of 'above temperature' meat from red meat slaughterhouses, outlining the application process for authorizations to transport partially chilled meat above the standard temperature requirements. This guidance aims to ensure food safety while accommodating specific technological needs in meat processing. (food.gov.uk)
In February 2026, the FSA updated its guidance on pet food labeling, emphasizing the requirements for declaring ingredients and the option to declare by category. This update aims to provide clarity to manufacturers and ensure transparency for consumers. (food.gov.uk)
These developments highlight the dynamic nature of the pharmaceutical and food regulatory landscape, underscoring the importance of staying informed about policy changes and approvals that may impact market access and compliance requirements.
